Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia

Secondary acute myeloid leukemia (sAML) is a high-risk AML evolving from heterogenous prior hematological disorders. Compared to de novo AML, sAML has even worse responses to current therapy and thus is associated with lower remission rates, inferior overall survival (OS) and higher relapse rates. M...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Oncol
Main Authors: Zhang, Hui, Gan, Wen-Ting, Hao, Wen-Ge, Wang, Peng-Fei, Li, Zhuo-Yan, Chang, Lung-Ji
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2020
Fag:
Oncology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7266936/
https://ncbi.nlm.nih.gov/pubmed/32528876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00685
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker